Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Epidural Electrical Stimulation to Support Hemodynamic Management in Individuals With Parkinson's Disease

NCT: NCT06920134 · RECRUITING

NCT IDNCT06920134
StatusRECRUITING
Start Date2025-07-03
Completion2031-05-01
SponsorEcole Polytechnique Fédérale de Lausanne (OTHER)
First posted
Last updated

Brief Summary

The PD-HemON study aims to evaluate the safety and preliminary efficacy of ARC-IM Therapy (Epidural Electrical Stimulation) to support hemodynamic management in people with typical and atypical Parkinson's Disease, who suffer from orthostatic hypotension.

Frequently Asked Questions

What is Epidural Electrical Stimulation to Support Hemodynamic Management in Individuals With Parkinson's Disease?

Epidural Electrical Stimulation to Support Hemodynamic Management in Individuals With Parkinson's Disease is a clinical trial registered under NCT06920134. Current status: RECRUITING.

What is the status of NCT06920134?

The current status of NCT06920134 (Epidural Electrical Stimulation to Support Hemodynamic Management in Individuals With Parkinson's Disease) is: RECRUITING.

When did Epidural Electrical Stimulation to Support Hemodynamic Management in Individuals With Parkinson's Disease start?

Epidural Electrical Stimulation to Support Hemodynamic Management in Individuals With Parkinson's Disease started on 2025-07-03.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑